2,4-Difluoro-N-(5-(4-(4-fluorobenzyl)-3-oxo-3,4-dihydro-2Hbenzo[b][1,4]oxazin-6-yl)-2-methoxypyridin-3-yl)benzenesulfonamide

ID: ALA4246422

PubChem CID: 145985068

Max Phase: Preclinical

Molecular Formula: C27H20F3N3O5S

Molecular Weight: 555.53

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ncc(-c2ccc3c(c2)N(Cc2ccc(F)cc2)C(=O)CO3)cc1NS(=O)(=O)c1ccc(F)cc1F

Standard InChI:  InChI=1S/C27H20F3N3O5S/c1-37-27-22(32-39(35,36)25-9-7-20(29)12-21(25)30)10-18(13-31-27)17-4-8-24-23(11-17)33(26(34)15-38-24)14-16-2-5-19(28)6-3-16/h2-13,32H,14-15H2,1H3

Standard InChI Key:  HLEUGVRJCJSRHC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 39 43  0  0  0  0  0  0  0  0999 V2000
    8.6583   -4.8083    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0750   -4.0959    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.2496   -4.0912    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.0791   -5.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0791   -6.5750    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7912   -6.9833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5032   -6.5750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5032   -5.7500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7912   -5.3334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2166   -6.9920    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.2134   -7.8179    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9231   -8.2313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.9295   -6.5795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6439   -6.9974    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.6372   -7.8252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3466   -8.2424    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.0673   -7.8367    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0741   -7.0090    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3600   -6.5871    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7923   -6.6030    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7912   -4.5084    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0767   -3.2709    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7979   -2.8596    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7983   -2.0354    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0833   -1.6279    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3665   -2.0390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3696   -2.8619    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.3634   -5.3396    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.6502   -5.7542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.3656   -5.7621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0828   -5.3544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.5112   -3.2742    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    9.0822   -0.8054    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   14.7940   -5.7740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5108   -5.3670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5167   -4.5412    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8001   -4.1240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0862   -4.5334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2334   -4.1325    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  4  9  2  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
 10 11  1  0
 10 13  2  0
 11 12  2  0
 12 15  1  0
 14 13  1  0
  7 10  1  0
 14 15  2  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
  9 21  1  0
 21  2  1  0
  2 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 27  2  0
 27 22  1  0
  4 28  1  0
 28 29  1  0
 19 30  1  0
 30 31  1  0
 23 32  1  0
 25 33  1  0
 31 34  2  0
 34 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  2  0
 38 31  1  0
 36 39  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4246422

    ---

Associated Targets(Human)

SNU-638 (372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 555.53Molecular Weight (Monoisotopic): 555.1076AlogP: 4.90#Rotatable Bonds: 7
Polar Surface Area: 97.83Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 6.58CX Basic pKa: 0.77CX LogP: 4.13CX LogD: 3.49
Aromatic Rings: 4Heavy Atoms: 39QED Weighted: 0.35Np Likeness Score: -1.76

References

1. Dong FD, Liu DD, Deng CL, Qin XC, Chen K, Wang J, Song HR, Ding HW..  (2018)  Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1,4]oxazin-3(4H)-one and 2H-benzo[b][1,4]oxazine scaffold derivatives as PI3Kα inhibitors.,  26  (14): [PMID:29937355] [10.1016/j.bmc.2018.06.022]

Source